INNOVATE BIOPHARMACEUTICLS I's ticker is INNT and the CUSIP is 45782F105. A total of 31 filers reported holding INNOVATE BIOPHARMACEUTICLS I in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $16,000 | -5.9% | 14,692 | 0.0% | 0.00% | – |
| Q2 2019 | $17,000 | -85.7% | 14,692 | -76.2% | 0.00% | – |
| Q1 2019 | $119,000 | -24.7% | 61,719 | -10.1% | 0.00% | – |
| Q4 2018 | $158,000 | -42.3% | 68,676 | +71.6% | 0.00% | – |
| Q3 2018 | $274,000 | -70.1% | 40,028 | +2.9% | 0.00% | – |
| Q2 2018 | $917,000 | – | 38,918 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SABBY MANAGEMENT, LLC | 1,336,248 | $1,550,000 | 1.95% |
| Hillview Capital Advisors, LLC | 19,610 | $23,000 | 0.12% |
| GSA CAPITAL PARTNERS LLP | 64,786 | $75,000 | 0.01% |
| Virtu Financial LLC | 62,822 | $73,000 | 0.00% |
| BREWIN DOLPHIN LTD | 25,000 | $29,000 | 0.00% |
| Paloma Partners Management Co | 89,694 | $104,000 | 0.00% |
| JANE STREET GROUP, LLC | 12,923 | $15,000 | 0.00% |
| UBS Group AG | 61 | $0 | 0.00% |
| BARCLAYS PLC | 240 | $0 | 0.00% |
| SIMPLEX TRADING, LLC | 337 | $0 | 0.00% |